Captor Therapeutics SA vs Nurix Therapeutics
Captor Therapeutics SA
Captor Therapeutics aims to treat cancer, infections, and diseases by targeting the difficult-to-drug proteome
79 employees · est. 2017 · Poland
Nurix Therapeutics
Nurix is writing medicine’s next chapter using targeted protein degradation as a new script to outmatch disease
370 employees · est. 2012 · Brisbane, United States
Nurix Therapeutics is the older company (2017 vs 2012); Nurix Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Captor Therapeutics SA | Nurix Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2012 older |
| Headquarters | ||
| Headquarters | Poland | Brisbane, United States |
| Employees | ||
| Employees | 79 | 370 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Pharmaceutical | Biotechnology |
| Funding Stage | ||
| Funding Stage | IPO | IPO |
| Total Funding | ||
| Total Funding | $68.50M | $759.15M |
| Funding Rounds | ||
| Funding Rounds | 3 | 9 |
| Services | ||
| Services | Drug discovery using Targeted Protein Degradation (TPD) technology, Development of therapeutics for cancer and autoimmune diseases, Structure-guided optimization of lead compounds | Development of degrader-based therapeutics, Collaborative pharmaceutical development, Clinical trial management and execution, Drug discovery utilizing DEL-AI technology |
| Target Customers | ||
| Target Customers | Healthcare providers, Pharmaceutical companies, Patients with severe conditions like cancer and autoimmune diseases, Research institutions | Patients with oncology, immunology, and neurology conditions, Pharmaceutical industry partners, Healthcare professionals and researchers |
| Taxonomy | ||
| Taxonomy | Targeted Protein DegradationDrug DiscoveryCancer TreatmentAutoimmune Disease TreatmentNeurodegenerative Disease TreatmentProteome Targeting +7 | Targeted Protein DegradationDegrader-based MedicinesUbiquitin-proteasome SystemTherapeutics DevelopmentLife SciencesDisease Treatment Innovation +4 |
| Website | ||
| Website | captortherapeutics.com | nurixtx.com |
About Captor Therapeutics SA
Captor Therapeutics SA is a pioneering company in the Biopharma, Biotechnology, and Pharmaceutical industries, headquartered in Poland. Founded in 2017, the company is publicly listed on the Warsaw Stock Exchange under the ticker WSE:CTX. Captor Therapeutics focuses on advancing drug discovery and...
About Nurix Therapeutics
Nurix Therapeutics, founded in 2012, is a United States-based biotechnology firm set on revolutionizing medical treatments through targeted protein degradation. Their slogan, "Nurix is writing medicine’s next chapter using targeted protein degradation as a new script to outmatch disease," reflects t...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches Captor Therapeutics SA and Nurix Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when Captor Therapeutics SA or Nurix Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare Captor Therapeutics SA with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Captor Therapeutics SA on 15 Jun 2026, and Nurix Therapeutics on 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
